Targeted delivery system for antisense oligonucleotides: A novel experimental strategy for neuroblastoma treatment

Cancer Letters

Volumn 197, Issue 1-2, 2003, Pages 231-235

  Brignole, Chiara ^a   Pagnan, Gabriella ^a   Marimpietri, Danilo ^a   Cosimo, Emilio ^a   Allen, Theresa M ^b   Ponzoni, Mirco ^a   Pastorino, Fabio ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibody; Antisense oligonucleotides; C myb; Coated cationic liposomes; Disialoganglioside GD2; GD2; Liposome; Neuroblastoma; Phosphorothioate; Targeted gene delivery system; Therapy

Indexed keywords

ANTIGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; GANGLIOSIDE GD2; LIPID; LIPOSOME; MONOCLONAL ANTIBODY; PROTEIN C MYB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CIRCULATION; CONTROLLED STUDY; COVALENT BOND; DOWN REGULATION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG TARGETING; ENCAPSULATION; HUMAN; HUMAN CELL; KIDNEY; LIVER; MOUSE; NEUROBLASTOMA; NEUROECTODERM; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SURFACE PROPERTY; TECHNIQUE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALIA;

EID: 0038782333     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00107-1     Document Type: Review

References (13)

1. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17:1999;2264-2279.
2. Ladenstein R., Philip T., Lasset C., Hartmann O., Garaventa A., Pinkerton R., Michon J., Pritchard J., Klingebiel T., Kremens B., Pearson A., Coze C., Paolucci P., Frappaz D., Gadner H., Chauvin F. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J. Clin. Oncol. 16:1998;953-965.
3. Stein C., Cheng Y.C. Antisense oligonucleotides as therapeutic agents. Is the bullet really magical? Science. 261:1993;1004-1012.
4. Leonetti C., Biroccio A., Benassi B., Stringaro A., Stoppacciaro A., Semple S.C., Zupi G. Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line. Cancer Gene Ther. 8:2001;459-468.
5. Wang S., Lee R.J., Cauchon G., Gorestein D.J., Low P.S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA. 92:1995;3318-3322.
6. Crooke S.T. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32:1993;329-376.
7. Henry S.P., Templin M.V., Gillet N., Rojko J., Levin A.A. Correlation of toxicity and pharmacokinetic properties of a phophorothioate oligonucleotide designed to inhibit ICAM-1. Toxicol. Pathol. 27:1999;95-100.
8. Alitalo K., Winquist R., Linn C.C., de La Chapelle A., Schwab M., Bishop J.M. Aberrant expression of an amplified c-myb oncogene in tow cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA. 81:1984;4534-4538.
9. Griffin C.A., Baylin S.B. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res. 45:1985;272-275.
10. Pagnan G., Stuart D.D., Pastorino F., Raffaghello L., Montaldo P.G., Allen T.M., Calabretta B., Ponzoni M. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD2-targeted immunoliposomes: antitumor effects. J. Natl. Cancer Inst. 92:2000;253-261.
11. Pastorino F., Stuart D.D., Ponzoni M., Allen T.M. Targeted delivery of antisense oligonucleotides in cancer. J. Controlled Rel. 74:2001;69-75.
12. Pastorino F., Pagnan G., Brignole C., Cosimo E., Marimpietri D., Raffaghello L., Ponzoni M., Montaldo P.G. Anti-GD2 immunoliposomes: a suitable system for the specific delivery of antisense oligonucleotides against oncogenes to neuroectodermal tumour cells. Res. Adv. Cancer. 2:2002;23-37.
13. Stuart D.D., Kao G.Y., Allen T.M. A novel long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1. Cancer Gene Ther. 7:2000;466-475.